Loading
Life sciences · Journal article
Revista Fisio&terapia. · September 9, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review exploring epigenetic and inflammatory pathways linking rheumatoid arthritis and periodontal disease, and proposing hyperbaric oxygen therapy as a potential immunomodulatory intervention. The evidence presented is mechanism-based and preliminary; no controlled trials, effect sizes, or hard clinical outcomes are reported to support clinical recommendation.
Narrative review. Individuals with rheumatoid arthritis and those with periodontal disease; specific clinical trial population not defined.
RA severity parameters (elevated erythrocyte sedimentation rate, protein C levels, multiple inflamed joints) are associated with periodontal bone loss Citrullinated proteins and genetic predisposition are associated with development of both arthritis and periodontal disease HBOT reduces cartilage destruction and keratan sulfate release in early post-injury period
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review does not provide sufficient evidence to guide clinical decision-making. The proposed links between epigenetics, RA, and periodontal disease are conceptually interesting but require validation through controlled studies; hyperbaric oxygen therapy for RA remains investigational.
A narrative review proposing mechanistic links between rheumatoid arthritis, periodontal disease, and epigenetics, with preliminary evidence for hyperbaric oxygen therapy; lacks controlled trials and hard clinical endpoints.
As stated by the source record.
This review does not provide sufficient evidence to guide clinical decision-making. The proposed links between epigenetics, RA, and periodontal disease are conceptually interesting but require validation through controlled studies; hyperbaric oxygen therapy for RA remains investigational.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Over the past 20 years, a highly significant interrelationship has been identified between rheumatoid arthritis and periodontal disease. The secretion of inflammatory mediators contributes to the destruction of periodontal and synovial tissues, respectively. These diseases share common risk factors and pathogenic pathways that lead to loss of function and disability. Parameters of RA (rheumatoid arthritis) severity, elevated erythrocyte sedimentation rate and protein C levels, as well as multiple inflamed joints, are associated with periodontal bone loss. The presence of citrullinated proteins, as well as genetic predisposition, is associated with the development of arthritis and periodontal disease (PD). Through epigenetics, we can understand how environmental and genetic factors may predispose individuals to the development of RA. There is growing evidence that epigenetic modifications play an important role in regulating the pathogenesis of RA. Treatment with HBOT (hyperbaric oxygen therapy) reduces the degree of cartilage destruction and the release of keratan sulfate during the first weeks after injury, suggesting an interruption of acute joint damage. HBOT has also been shown to decrease the expression of inducible nitric oxide synthase (iNOS), acting primarily on the immune and inflammatory response. HBOT has been shown to have an overall immunomodulatory effect, resulting in a positive effect by slowing autoimmune deterioration, as well as in cancer and vascular injuries, improving clinical markers by significantly reducing inflammation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.